Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.93 SEK | -2.11% | -1.06% | -79.61% |
Mar. 28 | Elicera Therapeutics AB Announces Director Changes | CI |
Mar. 06 | Elicera Enters Agreement with Prominent US Cancer Center to Evaluate the Use of ITANK in T-Cell Receptor Therapies | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-79.61% | 3.06M | |
+26.08% | 681B | |
+21.85% | 556B | |
-4.77% | 361B | |
+16.97% | 325B | |
+5.69% | 285B | |
+13.68% | 235B | |
+3.65% | 199B | |
-11.12% | 189B | |
-3.40% | 157B |
- Stock Market
- Equities
- ELIC Stock
- News Elicera Therapeutics AB
- Elicera Therapeutics to Proceed with Trial of Virus Oncolytic Virus Against Neuroendocrine Cancer